C-PEPTIDE DURING THE PROLONGED FAST IN INSULINOMA

被引:36
作者
SERVICE, FJ [1 ]
OBRIEN, PC [1 ]
MCMAHON, MM [1 ]
KAO, PC [1 ]
机构
[1] MAYO CLIN & MAYO FDN, DEPT LAB MED & PATHOL, CLIN BIOCHEM SECT, ROCHESTER, MN 55905 USA
关键词
D O I
10.1210/jc.76.3.655
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
C-Peptide, a marker for insulin secretion, is purported to be elevated in patients with insulinoma but diagnostic criteria have not been established. Thirty-seven patients with histologically confirmed insulinoma studied preoperatively, 19 normal subjects, and 2 patients who subsequently acknowledged self-administration of insulin underwent the prolonged fast (less-than-or-equal-to 72 h) according to a standard protocol. Plasma glucose, C-peptide, and insulin were measured every 6 h until plasma glucose was less than or equal to 3.3 mmol, then hourly until Whipple's triad was demonstrated or until 72 h without symptoms was reached. At the termination of the fasts, plasma was analyzed for sulfonylurea. Statistical analysis was by rank sum test. Data are expressed as median (range). The durations of fasts were 20 (2.5-68) h for patients with insulinomas and 72 h for normal subjects. At the end of fasts plasma glucose, C-peptide, and insulin concentrations were 2.2 (1.4-2.9) vs. 3.6 (2.7-5.5) mmol, P < 0.001; 0.60 (0.20-1.92) vs. 0.13 (0.07-0.43) nmol, P < 0.001; and 126 (35-840) us. 35 (35-126) pmol, P < 0.001, respectively, for insulinoma patients and normal subjects. All plasma samples were negative for sulfonylurea. Insulinoma patients had C-peptide values at the end of the fasts greater than or equal to 0.20 nmol whereas normal subjects and patients with insulin factitial hypoglycemia had C-peptide concentrations less than or equal to 0.10 nmol when plasma glucose was less than or equal to 2.8 mmol. Insulinoma is confirmed in a sulfonylurea negative patient with Whipple's triad during the prolonged fast and a concomitant C-peptide concentration greater than or equal to 0.20 nmol.
引用
收藏
页码:655 / 659
页数:5
相关论文
共 35 条
  • [1] Biliotti G C, 1983, Ital J Surg Sci, V13, P41
  • [2] DOHERTY GM, 1991, SURGERY, V110, P989
  • [3] INSULIN-PRODUCING ISLET CELL TUMORS
    FAJANS, SS
    VINIK, AI
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1989, 18 (01) : 45 - 74
  • [4] FASTING HYPOGLYCEMIA IN ADULTS
    FAJANS, SS
    FLOYD, JC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (14) : 766 - 772
  • [5] GERBITZ KD, 1985, J CLIN CHEM CLIN BIO, V23, P377
  • [6] FACTITIOUS HYPOGLYCEMIA DUE TO SURREPTITIOUS ADMINISTRATION OF INSULIN - DIAGNOSIS, TREATMENT, AND LONG-TERM FOLLOW-UP
    GRUNBERGER, G
    WEINER, JL
    SILVERMAN, R
    TAYLOR, S
    GORDEN, P
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) : 252 - 257
  • [7] BLOOD SUGAR, SERUM INSULIN AND FREE FATTY ACID INTERRELATIONSHIPS DURING INTRAVENOUS TOLBUTAMIDE TESTING IN NORMAL YOUNG ADULTS AND IN PATIENTS WITH INSULINOMA
    GRUNT, JA
    PALLOTTA, JA
    SOELDNER, JS
    [J]. DIABETES, 1970, 19 (02) : 122 - +
  • [8] RADIOIMMUNOLOGICAL DETERMINATION OF HUMAN C-PEPTIDE IN SERUM
    HEDING, LG
    [J]. DIABETOLOGIA, 1975, 11 (06) : 541 - 548
  • [9] KADISH AH, 1968, CLIN CHEM, V14, P116
  • [10] INGESTION OF A MIXED MEAL DOES NOT AFFECT THE METABOLIC-CLEARANCE RATE OF BIOSYNTHETIC HUMAN C-PEPTIDE
    LICINIOPAIXAO, J
    POLONSKY, KS
    GIVEN, BD
    PUGH, W
    OSTREGA, D
    FRANK, BF
    RUBENSTEIN, AH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (02) : 401 - 403